Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

MD Anderson Cancer Center Joins ITUS Early Cancer Detection Biomarker Study

December 7, 2016

ITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study Results

December 7, 2016

ITUS Executive Chairman Dr. Amit Kumar Appointed to American Cancer Society National Board of Directors

November 30, 2016

ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with 6 Additional Cancer Types

November 15, 2016

ITUS Demonstrates Efficacy of its Cchek(TM) Early Cancer Detection Platform with Pancreatic Cancer

October 25, 2016

ITUS Hires Michael Catelani as Chief Financial Officer

October 24, 2016

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 17, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Thyroid Cancer

October 12, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Liver Cancer

October 3, 2016

ITUS Demonstrates Efficacy of Its Cchek(TM) Early Cancer Detection Platform With Ovarian Cancer

September 30, 2016

RSS
  • 1
  • 2
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

May 22, 2023

Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial

Read More...
Apr 17, 2023

Anixa Biosciences Clarifies Poster Presentation on Company Website

Read More...
Apr 17, 2023

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine

Read More...
Copyrights © 2023 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap